Is COLL a Buy, Before Earnings?
PremiumPre-EarningsIs COLL a Buy, Before Earnings?
5d ago
Collegium Pharmaceutical management to meet with Piper Sandler
Premium
The Fly
Collegium Pharmaceutical management to meet with Piper Sandler
1M ago
Collegium Pharmaceutical price target raised to $50 from $47 at H.C. Wainwright
Premium
The Fly
Collegium Pharmaceutical price target raised to $50 from $47 at H.C. Wainwright
2M ago
Collegium Pharmaceutical Releases Earnings Insights
PremiumCompany AnnouncementsCollegium Pharmaceutical Releases Earnings Insights
3M ago
Collegium Pharmaceutical sees FY24 net product revenues of $580M-$595M
Premium
The Fly
Collegium Pharmaceutical sees FY24 net product revenues of $580M-$595M
3M ago
Collegium Pharmaceutical reports Q2 adjusted EPS $1.62, consensus $1.51
Premium
The Fly
Collegium Pharmaceutical reports Q2 adjusted EPS $1.62, consensus $1.51
3M ago
Collegium Pharmaceutical backs FY24 net product revenue view $580M-$595M
PremiumThe FlyCollegium Pharmaceutical backs FY24 net product revenue view $580M-$595M
3M ago
Collegium Pharmaceutical sees Q2 net product revenue ~$145M, up 7% y/y
Premium
The Fly
Collegium Pharmaceutical sees Q2 net product revenue ~$145M, up 7% y/y
3M ago
Collegium Pharmaceutical to acquire Ironshore Therapeutics for $525M in cash
Premium
The Fly
Collegium Pharmaceutical to acquire Ironshore Therapeutics for $525M in cash
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100